{"id":"f-rh-v14","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of thromboembolic events"},{"rate":"null","effect":"Hypertension"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"RH-V14 works by binding to the erythropoietin receptor, triggering a cascade of intracellular signaling events that ultimately lead to the production of red blood cells. This is particularly useful in patients with anemia due to chronic kidney disease or other conditions. By stimulating erythropoiesis, RH-V14 helps to increase red blood cell count and alleviate symptoms of anemia.","oneSentence":"RH-V14 is a recombinant human erythropoietin used to stimulate erythropoiesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:24:39.622Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anemia due to chronic kidney disease"},{"name":"Anemia due to cancer chemotherapy"}]},"trialDetails":[{"nctId":"NCT04713670","phase":"PHASE4","title":"Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2021-03-10","conditions":"H. Pylori Infection","enrollment":1200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"(F) RH-V14","genericName":"(F) RH-V14","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"RH-V14 is a recombinant human erythropoietin used to stimulate erythropoiesis. Used for Anemia due to chronic kidney disease, Anemia due to cancer chemotherapy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}